EPO Patents = 2

Forward Citations = 11

Loading Chart...

10 inventors (with patents filed for the assignee):

Rudolf Aebersold (2 out of 15 patents)

Silke Gillessen (2 out of 4 patents)

Wilhelm Krek (2 out of 2 patents)

4. Igor Cima (2 out of 2 patents)

5. Ralph Schiess (2 out of 3 patents)

6. Thomas Cerny (2 out of 2 patents)

7. Xavier Duportet (1 out of 23 patents)

8. Cristina Del Carmen Gil-Cruz (1 out of 5 patents)

9. Christian Ivan Pérez-Shibayama (1 out of 5 patents)

10. Burkhard Ludewig (1 out of 5 patents)

11. Jean-Yves Fournier (0 patent)

12. Abel-Jan Tasman (0 patent)

3 patents: Sort by Forward Citations

1. 11617773 - Elimination of colonic bacterial driving lethal inflammatory cardiomyopathy (2023-04-04),

2. 10151755 - Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith (2018-12-11),

3. 9377463 - Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith (2016-06-28),

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

3 Patents

#27 in St. Gallen

#2,402 in Switzerland

St. Gallen, Switzerland

Kantonsspital St. Gallen

Forward Citations = 11

10 inventors:

Rudolf Aebersold (2 out of 15 patents)

Silke Gillessen (2 out of 4 patents)

Wilhelm Krek (2 out of 2 patents)

4. Igor Cima (2 out of 2 patents)

5. Ralph Schiess (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kantonsspital St. Gallen. Retrieved from https://idiyas.com/company/kantonsspital-st-gallen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]